Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Emini

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibodyA J Conley, J A Kessler, L J Boots, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Active human immunodeficiency virus protease is required for viral infectivityN E Kohl, E A Emini, W A Schleif, et al.
Journal of Virology|September 1, 1991
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsJ H Nunberg, W A Schleif, E J Boots, et al.
The Journal of Infectious Diseases|August 11, 1998
Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variablesG L Drusano, J A Bilello, D S Stein, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays comparedJ C Kappes, M S Saag, G M Shaw, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Nature|February 20, 1992
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibodyE A Emini, W A Schleif, J H Nunberg, et al.
Journal of Medical Virology|May 1, 1989
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface proteinE A Emini, V Larson, J Eichberg, et al.
Vaccine|May 31, 2011
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 yearsT F Schwarz, J Flamaing, H C Rümke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1993
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeysY Yasutomi, S Koenig, S S Haun, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibodyA J Conley, J A Kessler, L J Boots, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Active human immunodeficiency virus protease is required for viral infectivityN E Kohl, E A Emini, W A Schleif, et al.
Journal of Virology|September 1, 1991
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitorsJ H Nunberg, W A Schleif, E J Boots, et al.
The Journal of Infectious Diseases|August 11, 1998
Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variablesG L Drusano, J A Bilello, D S Stein, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays comparedJ C Kappes, M S Saag, G M Shaw, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Nature|February 20, 1992
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibodyE A Emini, W A Schleif, J H Nunberg, et al.
Journal of Medical Virology|May 1, 1989
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface proteinE A Emini, V Larson, J Eichberg, et al.
Vaccine|May 31, 2011
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 yearsT F Schwarz, J Flamaing, H C Rümke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1993
Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeysY Yasutomi, S Koenig, S S Haun, et al.
Pageof 10